Right Submission has changed the way that biotechnology companies handle regulatory applications by streamlining the submission process and ensuring accuracy and completeness, thereby achieving FDA clearance faster.
Because of the nature of their offering, Right Submission has a rigidly defined target audience that responds to a certain type of messaging, and so we worked closely with them to develop that messaging and to identify the best way to reach their target audience. The aim was to ensure that all prospects could understand the value that the company had to offer.
The result was a bespoke strategy which was designed to target medical device companies in the US and across Europe while customizing the messaging using unique data points about each prospect. Marketing is all about reaching the right person in the right place with the right message at the right time, so it’s no surprise that the approach worked well. We were able to generate 30 hot leads from over 2,000 prospects in the initial campaign.
"We were taken aback by the success of the campaign and we’re so glad that we found Bant.io. We were sceptical at first because our target audience is so specific, but Bant.io explained that having a specific target audience can actually make it easier. That certainly seems to be the case if the results are anything to go by. We can’t wait to see what the future brings!"
Marek Herrmann-Nowosielski - CEO & Co-Founder
Client: Right Submission
Right Submission asked Bant.io for help expanding their presence in the US and European markets.
2131 prospective clients reached;
3 email sequences developed;
5 A/B tests performed.
34% Open rate;
27% Response rate;
15% Conversions to Opportunities;
30 Hot Leads.